Bioregulators Peptides

Khavinson Bioregulator Peptides

Bioregulator peptides are ultra-short (2-4 amino acid) sequences developed by Professor Vladimir Khavinson at the Saint Petersburg Institute of Bioregulation and Gerontology. Each bioregulator targets a specific organ system, binding to complementary DNA segments to modulate gene expression and protein synthesis. With over 40 years of clinical research across thousands of patients, Khavinson bioregulators represent one of the most extensively studied families of short peptides in the world.

Key Research Highlights

• 16 organ-specific bioregulators covering cardiovascular, immune, endocrine, hepatic, pulmonary, and neural systems
• Each peptide is 2-4 amino acids - small enough to cross cellular membranes without receptor binding
• Pinealon research focuses on circadian rhythm regulation and pineal gland function
• All bioregulators are supplied as lyophilized powder, 99%+ purity with published certificates of analysis

Bioregulator Target Map

Also available: Prostamax, Ovagen, Vesugen, Vilon, Cartalax, Chonluten, Pancragon, Vesilute

Mechanism of Action

Unlike receptor-mediated peptides, bioregulators operate through a gene-regulatory mechanism. Their short amino acid sequences penetrate the cell nucleus and interact with specific DNA regions, activating dormant genes responsible for protein synthesis in the target organ. This epigenetic approach means bioregulators work to restore the tissue's own regenerative capacity rather than introducing external signals.

Reconstitution & Dosing

Bioregulators are supplied as lyophilized powder and require bacteriostatic water for reconstitution. Use our reconstitution calculator to determine precise volumes, and the dosage calculator for accurate measurements. All 16 bioregulators are standardized at 20mg per vial, 10 vials per kit.